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        Introduction 
  Translational silencing can determine one of several pathways 
for the messenger RNP (mRNP): fi  rst, the mRNP can be kept 
silent until it is eventually reactivated for translation, mRNA 
storage. This pathway is particularly well studied in the early 
developmental stages of insect or amphibian oocytes (  Seydoux, 
1996  ). In this case, mRNA silencing is achieved by shortening 
the poly(A) tail to a critical length that no longer supports trans-
lation initiation. Activation of the mRNA consequently involves 
lengthening of the poly(A) tail in a process that is referred to as 
  “  cytoplasmic polyadenylation.  ”   In vertebrates, this process re-
quires a characteristic, uridine-rich cytoplasmic polyadenyl-
ation element in vicinity to the 3   end of the mRNA. Cytoplasmic 
polyadenylation elements are recognized by the cytoplasmic 
polyadenylation element binding (CPEB) protein, the binding 
of which causes an inhibition of cap-dependent translation. 
After a critical phosphorylation, CPEB recruits the cytoplasmic 
polyadenylation machinery to the mRNA and thereby activates 
translation (  Mendez and Richter, 2001  ). Another example of 
mRNA storage is the evolutionarily conserved translational 
shutdown that occurs in response to cellular stress: the respec-
tive signaling cascades cause phosphorylation of the translation 
initiation factor eIF2    , which blocks translation initiation of 
most mRNAs at the 48S pretranslational complex (  Anderson 
and Kedersha, 2002  ). 
  Second, the silenced mRNPs can be transported to subcel-
lular compartments, to be translated there. Local protein synthe-
sis is very important in polarized cells, as it is crucial for the 
maintenance of the specialized functions in the respective com-
partments. This is best exemplifi  ed by the neuronal axons and 
dendrites: in the growing axons, local translation plays a crucial 
M
essenger RNA (mRNA) transport to neuronal 
dendrites is crucial for synaptic plasticity, but 
little is known of assembly or translational regu-
lation of dendritic messenger ribonucleoproteins (mRNPs). 
Here we characterize a novel mRNP complex that is found 
in neuronal dendrites throughout the central nervous sys-
tem and in some axonal processes of the spinal cord. The 
complex is characterized by the LSm1 protein, which so 
far has been implicated in mRNA degradation in non-
neuronal cells. In brain, it associates with intact mRNAs. 
Interestingly, the LSm1-mRNPs contain the cap-binding 
protein CBP80 that associates with (pre)mRNAs in the 
nucleus, suggesting that the dendritic LSm1 complex has 
been assembled in the nucleus. In support of this notion, 
neuronal LSm1 is partially nuclear and inhibition of mRNA 
synthesis increases its nuclear localization. Importantly, 
CBP80 is also present in the dendrites and both LSm1 and 
CBP80 shift signiﬁ  cantly into the spines upon stimulation 
of glutamergic receptors, suggesting that these mRNPs 
are translationally activated and contribute to the regu-
lated local protein synthesis.
  Dendritic LSm1/CBP80-mRNPs mark the early steps 
of transport commitment and translational control 
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P bodies are on the one hand mRNA degradation centers, on the 
other hand they can also store stress-silenced mRNAs in yeast 
(  Brengues et al., 2005  ) and microRNA-silenced mRNA in higher 
eukaryotes (  Filipowicz et al., 2008  ). In insects, there appears to 
be a huge overlap between P body markers and neuronal trans-
port granules (  Barbee et al., 2006  ). 
  Here, we show that the auxiliary mRNA degradation factor 
LSm1 has a second function in neurons in that it forms stable 
dendritic mRNPs. The LSm1 mRNPs contain the CBP80 subunit 
of the nuclear cap-binding complex, indicating that the localized 
mRNP was assembled in the nucleus, thus linking mRNA trans-
port to nuclear events. In support of this notion, the otherwise 
predominantly cytoplasmic protein LSm1 becomes partially nu-
clear upon inhibition of novel mRNA synthesis and hence export. 
Further, LSm1 mRNPs contain the cytoplasmic polyadenylation 
element binding factor CPEB. Finally, we show that both CBP80 
and LSm1 migrate into the spines after mGluR stimulation, a 
typical sign of their regulated activation. 
  Results 
  The LSm proteins localize in the dendrites 
in vitro and in vivo 
  As we were interested in the expression of the auxiliary mRNA 
degradation factors LSm1 to LSm7 in the neuronal system, we 
looked at the subcellular localization of the LSm proteins in pri-
mary neuronal cells. We used antibodies directed against LSm1 
( Ingelfi  nger et al., 2002  ; Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200807033/DC1). Primary neurons were pre-
pared from two different rat tissues, namely the spinal cord and 
the cerebellum, and labeled with affi  nity-purifi  ed    -LSm1  anti-
bodies. To identify the neurons and at the same time reveal the 
neurites, the slides were counterstained with a monoclonal 
    -MAP2 antibody. As shown in   Fig. 1  , neurons derived from the 
spinal cord ( Fig. 1 , A – D) show a prominent, punctuated signal for 
LSm1 in the cell body (  Fig. 1 A  , arrow), probably the mRNA-
degrading P bodies. In addition, LSm1 is also highly expressed in 
the dendrites (  Fig. 1 A  , arrowhead), which is shown by the colo-
calization with the dendritic marker MAP2 (  Fig. 1 C  , yellow), 
thus confi  rming and extending a recent observation (  Vessey et al., 
2006  ). As we used affi  nity-purifi  ed antibodies, we were able to 
determine the LSm1 distribution with high resolution: the den-
dritic LSm1 is present in apparently granular structures (  Fig. 1 D  ). 
The spinal cord neurons were not further separated, and motor 
neurons and interneurons as well as glia cells are present. All 
neurons have LSm1 present in the neurites (unpublished data). 
Moreover, when spinal cord neurons were grown in the presence 
of FBS, the neurons tended to cluster and send bundles of multi-
ple neurites to nearby cell clusters. In these bundles, the granular 
structure of the LSm1 signal becomes very evident (  Fig. 1  , E  –  H, 
the MAP2-positive cell in the middle lies on top of the bundle and 
the MAP2-negative cell at the right is presumably a glial cell). 
  Rat cerebellar cells were cultured to enrich the Purkinje 
neurons and their identity was verifi  ed by staining for Calbindin 
that, in cerebellum, marks the dendrites specifi  cally of the Pur-
kinje cells (unpublished data). As for the spinal cord neurons, 
LSm1 is highly present in the dendrites (  Fig. 1 I  ). 
role in pathfi  nding (  Piper and Holt, 2004  ) and is therefore indis-
pensable for the establishing of the proper connections in the ner-
vous system. In the dendrites, synaptic stimulation causes a shift 
of mRNP components (  Steward and Schuman, 2003  ;   Martin and 
Zukin, 2006  ;   Ferrari et al., 2007  ) and ribosomes (  Ostroff et al., 
2002  ) into the dendritic spines, where translation is activated. 
The encoded proteins help to modulate the synaptic strength in 
response to the stimulation, which is the molecular basis of 
learning and memory. Several proteins have been associated 
with dendritic mRNAs and implicated in their transport, among 
them the zip-code binding protein ZBP1 (  Zhang et al., 2001  ), 
the Fragile X mental retardation protein FMRP (  Bagni and 
Greenough, 2005  ), and Staufen (  K  ö  hrmann et al., 1999  ;   Villac  é   
et al., 2004  ). Despite this knowledge, the process of selection of 
dendritic mRNAs and their transport into the dendrites remains 
largely enigmatic. 
  Finally, the silenced mRNA can be degraded. Regulated 
mRNA degradation frequently starts with deadenylation, either 
through consecutive shortening of the poly(A) tail or by an 
endonucleolytic cleavage in the 3     UTR. Deadenylation at the 3    
terminus then causes decapping at the 5     end and 5    → 3    exo-
nucleolytic degradation (  Meyer et al., 2004  ). In addition to the 
decapping enzyme and the exonuclease, the process requires the 
activity of several auxiliary factors, such as the seven LSm pro-
teins, LSm1  –  7. The LSm proteins associate with the mRNAs 
that are targeted for degradation (  Tharun and Parker, 2001  ) and 
are required for effi  cient decapping in yeast (  Tharun et al., 
2000  ). In mammals, the LSm proteins act upstream of the de-
grading enzymes (  Cougot et al., 2004  ;   Andrei et al., 2005  ) and 
are probably involved in translational silencing before degrada-
tion (the LSm1-associated factor Pat1p inhibits translation in 
yeast [  Coller and Parker, 2005  ]). The LSm (  “  Like Sm  ”  ) proteins 
take their name from a sequence homology to the Sm proteins 
that constitute the core of the spliceosomal small nuclear RNP 
complexes: they are essential pre-mRNA splicing factors. Simi-
larly, all characterized LSm proteins are involved in various 
steps of mRNA metabolism. The Sm/LSm proteins share a com-
mon domain that is responsible for the fact that seven family 
members form a circular complex. In vivo assembly of the Sm 
complex proper requires catalysis by the survival of motor neu-
rons (SMN) protein and associated factors (  Meister et al., 2002  ). 
Insuffi  cient expression of SMN causes a selective degeneration 
of      motor neurons, a condition called spinal muscular atrophy. 
How insuffi  ciency of a general splicing factor can have such a 
selective effect remains enigmatic; possibly SMN has a second 
function. LSm4 has been implicated because it contains the high 
affi  nity SMN-binding domain that is also found in the Sm pro-
teins (  Brahms et al., 2001  ;   Friesen et al., 2001  ), but none of the 
processes that require LSm proteins is specifi  c for neurons. 
  mRNA silencing by any of the aforementioned mecha-
nisms can coincide with aggregation of the respective mRNPs 
into cytoplasmic granules: the polar granules in the case of ma-
ternally stored mRNAs in insects, the stress granules in case of 
stress-induced shutdown of translation, the transport granules in 
the case of mammalian dendritic transport, and the P bodies in 
the case of mRNAs that undergo degradation. The distinction be-
tween the various types of mRNA granules is not always clear: 425 LSM, CBP80, AND CPEB IN A DENDRITIC   M  RNP   • di Penta et al. 
in   Fig. 2 A  . In the cerebral and cerebellar cortices, all LSm1-
positive cells are characterized by a granular distribution of the 
staining, which is often present also at considerable distances 
from the cell bodies (  Fig. 2 A  , a, d, and g). Double labeling with 
LSm1 and different markers (neurofi  lament heavy chain [NF-H], 
SMI31, or SMI 32) capable to evidence both neuronal dendrites 
and axons show a signifi  cant localization of LSm1 in these neuro-
nal processes (dendrites are shown by arrowheads in   Fig. 2 A  , d). 
In the cerebral cortex as well as in the cerebellum, both large 
neurons, pyramidal and Purkinje cells, as well as small ones, 
possibly interneurons, are LSm1 positive. Furthermore, double 
labeling with the marker glial fi  brillary acidic protein (unpub-
lished data) suggests that glial cells also express LSm1. Expres-
sion of LSm1 in neuronal cell bodies and dendrites is present 
throughout the brain: double labeling of LSm1 with different 
specifi  c markers demonstrates its presence in the cerebellar cor-
tex (  Fig. 2   A, g  –  i), as well as in hippocampus, thalamus, hypo-
thalamus, and substantia nigra pars compacta (Fig. S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200807033/DC1). In-
terestingly, no expression of LSm1 is present in the presynaptic 
  To determine whether other components of the LSm com-
plex are also present in the neurites, we stained primary neurons 
with affi  nity-purifi  ed     -LSm4 antibodies, again counterstaining 
with the     -MAP2 antibody. As expected, we observed a very 
prominent signal in the nucleus of the neurons, because LSm4 
is not only part of the cytoplasmic LSm1-7 complex but also of 
the nuclear U6 small nuclear RNP (  Achsel et al., 1999  ). In ad-
dition, LSm4 is clearly visible also in the neurites of both spinal 
cord neurons (  Fig. 1 Q  ) and in Purkinje cells (  Fig. 1 U  ). In con-
clusion, we found the LSm proteins in the cell body of various 
neurons where they presumably have the same roles as in im-
mortalized cell lines: mRNA splicing in the nucleus and mRNA 
degradation in the cytoplasm. In addition, the LSm proteins are 
present in the neurites of the cells, the function of which is not 
immediately clear. 
  Next, we investigated the distribution of LSm1 proteins in 
the rat central nervous system in vivo. LSm1 is expressed 
throughout the central nervous system with positive cells of dif-
ferent size and shape present in virtually all areas. Exemplarily, 
sections from the cerebral cortex and the cerebellum are shown 
  Figure 1.       LSm1 and LSm4 localize in the neurites of 
primary neurons.   Rat spinal cord neurons were cul-
tured in the presence of B27 supplement (A  –  D and 
N  –  Q) or of serum (E  –  H) for 7 DIV; cerebellar Purkinje 
cells were cultured as described in Materials and meth-
ods for 7 DIV (I  –  M and R  –  U). Cells were stained with 
monoclonal     -MAP2 antibody (green) and polyclonal 
    -LSm1 (A  –  M, red) or     -LSm4 antibodies (N  –  U, red). 
Shown are confocal micrographs of the separated 
channels and the merged images. Red arrow (LSm1 in 
the cell body) and arrowhead (in the dendrites) indi-
cate regions of interest as described in the text. White 
boxes indicate the area enlarged in the subsequent 
panel. Bars, 10   μ  m.     JCB • VOLUME 184 • NUMBER 3 • 2009  426
terminals, at least of the deep cerebellar nuclei. As shown in 
  Fig. 2 B   (a  –  c), LSm1 is well expressed in the cell bodies, but 
does not colocalize with the presynaptic marker synaptophysin 
that surrounds the neurons (  Fig. 2 B  , green in the merged image 
and white arrows). In axons, LSm1 labeling is not consistent. 
This is exemplifi  ed by differences between the LSm1 labeling in 
the corpus callosum, one of the major fi  ber tracts of the brain, 
and in the spinal cord. In the corpus callosum, only interspersed 
cell bodies exhibit LSm1 signals next to the nuclei (  Fig. 2 B  , 
d and f, red arrows; the nuclei are highlighted by blue DAPI 
staining), whereas fi  bers, indicated by NF-H labeling of axons, 
do not colocalize with LSm1 (  Fig. 2 B  , f). In the spinal cord, the 
picture is different.   Fig. 2 B   (g  –  i) shows an overview over a 
transversal section, with the gray matter outlined by a dashed 
line. Both cell bodies and dendritic structures in this area express 
LSm1 as well as NF-H. Zooming in on the ventral border of the 
gray matter, it becomes evident that axonal fi  bers in the white 
matter also express LSm1 (  Fig. 2 B  , k  –  m, white arrows). As this 
is the region where axons leave toward the ventral root, these 
structures can be tentatively identifi  ed as the axons of      moto-
neurons. In conclusion, LSm1 is expressed in glial and in many 
neuronal cell types, and it is present, albeit to varying degrees, in 
dendrites. As regards to axons, in contrast, LSm1 has been 
clearly localized only in spinal cord fi  bers. 
  LSm1 is part of stable mRNPs 
  As the LSm proteins are involved in mRNA metabolism, it was 
tempting to speculate that the dendritic LSm1 population also 
associates with mRNAs. To test this notion, we performed 
immunoprecipitation experiments with affi  nity-purifi  ed    -LSm1 
antibodies, using total rat brain extracts. RNAs that coprecipi-
tate with LSm1 were isolated, and the presence of specifi  c 
mRNAs was revealed by RT-PCR. We tested four mRNAs that 
are known to be localized in neurites (  Steward and Schuman, 
2003  ;   Tsokas et al., 2005  ), namely the mRNAs coding for    -actin, 
MAP1B, CaMKII    , and eEF1    1. As shown in   Fig. 3 A  , all four 
mRNAs coprecipitate with LSm1 (lanes 3, 6, 9, and 12) but not 
in the precipitation with unspecifi  c IgGs (lanes 2, 5, 8, and 11). 
We conclude that, in rat brain extracts, LSm1 stably associates 
with mRNPs that have been reported to localize in the dendrites. 
To test whether LSm1 directly binds to the mRNAs in the rat 
brain, we used a cross-linking/immunoprecipitation protocol 
(  Ule et al., 2003  ). Under the highly stringent conditions of the 
RIPA buffer, most protein  –  protein and protein  –  RNA interac-
tions are broken, and mRNAs did not coprecipitate with LSm1 
(  Fig. 3 B  , lane 2). When the tissue is UV irradiated before ex-
tract preparation, mRNAs that are in molecular contact are co-
valently linked to LSm1 and therefore coprecipitate even under 
stringent conditions (  Fig. 3 B  , lanes 3 and 4). Therefore, the UV-
dependent precipitation of the     -actin, MAP1B, and eEF1   1 
mRNAs demonstrates that these molecules are in direct contact 
  Figure 2.       LSm1 localizes in vivo in neuronal cell bodies and neurites. 
  (A) LSm1 is found in dendrites. Rat brain slices were stained with     -LSm1 
(a, d, and g) as well as with the     -neuroﬁ  lament antibody SMI31 (b and e) 
or     -Calbindin (h). Images were acquired by confocal microscopy. Shown 
are the retrosplenial granular cortex (a  –  f) and the cerebellar cortex (g  –  i). 
(d) Arrowheads highlight     -LSm1  –  positive granular structures in pyramidal 
neurons and arrows point to similar structures in small cells. (g) Arrows 
point to     -LSm1  –  positive granular structures in Purkinje cells and inter-
neurons and arrowheads show similar structures in the dendritic tree of the 
Purkinje cells. Bars: (a) 100   μ  m; (d) 20   μ  m; (g) 40   μ  m. (B) LSm1 is found 
only in some axonal structures. Shown are the deep cerebellar nuclei (a  –  c), 
the corpus callosum (d  –  f), and a transversal section of the spinal cord (g  –  m); 
k  –  m shows the detail boxed in g  –  i. The sections were stained with     -LSm1 
(a, d, g, and k),     -synaptophysin (b), and     -NF-H (SMI32 antibody; e, h, 
and i). White arrows (c) point to presynaptic structures void of LSm1 signal 
and red arrows (d and f) point to     -LSm1 immunoreactivity associated 
with cell nuclei. The dashed line in g  –  m indicates the gray-to-white matter 
boundary and white arrows point to LSm1 signals present in neuroﬁ  lament-
positive ﬁ  bers, presumably axons, in the white matter. Bars: (a) 20   μ  m; 
(f) 10   μ  m; (i) 200   μ  m; (m) 30   μ  m.     
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  To characterize the LSm1 mRNP biochemically, we 
loaded the brain extract (virtually void of nuclei) on sucrose 
gradients to separate complexes by size. Extract preparation and 
gradient conditions were established to give an optimal yield 
and spread of the LSm1 protein (  Fig. 4 A  , top). It was not in-
tended to infer association with polysomes from the sedimenta-
tion velocity, and the distribution of ribosomes (  Fig. 4 A  , 
bottom) was analyzed solely to estimate the size of complexes 
present in the various fractions (indicated at the top of   Fig. 4 A  ). 
The bulk of LSm1 sediments in the two top fractions, indicating 
a very small complex, if not monomeric protein. In addition, 
detectable LSm1 levels are observed in all fractions, which cor-
responds to complexes of up to 80S and more. To determine the 
size of the LSm1 mRNP, extracts were irradiated with UV light 
before loading onto the sucrose gradient. Even-numbered frac-
tions were immunoprecipitated under the stringent conditions 
used in   Fig. 3 B   to reveal the sedimentation of mRNPs where 
LSm1 is in molecular contact with the pre-mRNA. The stron-
gest signal for both MAP1B and     -actin mRNA is obtained in 
the bottom half of the gradient, where LSm1 is underrepre-
sented. In the top half, and especially in the top fraction where 
LSm1 is most abundant, the signal is much weaker (  Fig. 4 B  ). 
Thus, only a small percentage of LSm1 is assembled, at steady 
state, into large mRNPs. 
  LSm1 mRNPs contain the CPEB protein 
and the nuclear cap-binding protein CBP80 
  To further characterize the composition of the LSm1 mRNPs, 
we coupled the sucrose gradient centrifugation with an immuno-
precipitation step. The above gradients (without UV irradia-
tion) were arbitrarily divided into three pools of fractions: 
with LSm1 (  Fig. 3 B  , fi  rst three panels). We further checked for 
the coprecipitation of other dendritic mRNAs: the IP  3   receptor 
Iptr1/Pcp-1 and the Purkinje cell protein Pcp-2 are highly ex-
pressed in the Purkinje cells and their mRNA is also dendritic 
(  Iijima et al., 2005  ). Both mRNAs cross-link to LSm1 (  Fig. 3 B  , 
fourth and fi  fth panels) in agreement with the notion that LSm1 
in the dendrites associates with mRNAs. Arc/Arg3.1, fi  nally, is 
an mRNA that localizes in hippocampal dendrites and that is 
regulated by nonsense-mediated mRNA degradation (  Giorgi 
et al., 2007  ). Because LSm1 is an auxiliary mRNA degradation 
factor, even though it is not implicated in nonsense-mediated 
decay, we checked for association with this mRNA. Arc mRNA 
is not detected in the immunoprecipitate, showing the specifi  c-
ity of the method (  Fig. 3 B  , sixth panel); only a longer fragment 
is detected, the length of which corresponds to the Arc/Arg3.1 
pre-mRNA (  Fig. 3 B  , asterisk). 
  Figure 3.       LSm1 binds stably and directly to mRNAs.   (A) Immunoprecipita-
tions were performed from rat brain extracts with afﬁ  nity-puriﬁ  ed     -LSm1 
antibodies (lanes 3, 6, 9, and 12) or with an equal amount of nonspeciﬁ  c 
IgGs (lanes 2, 5, 8, and11). Coprecipitated RNA was isolated and ana-
lyzed by RT-PCR using oligos speciﬁ  c for the     -actin, MAP1B, CaMKII    , 
and eEF1    1 mRNAs. Shown is the product of the PCR reactions. In lanes 
1, 4, 7, and 10, RT-PCR was performed on 1/50 of the extract used in 
each precipitation. The migration of DNA markers is indicated on the left. 
(B) Rat brain was UV irradiated for 0, 45, and 90 s (lanes 2  –  4), extract 
was prepared as before, and LSm1 immunoprecipitations were performed 
under semidenaturing conditions. Coprecipitating mRNAs were visualized 
by RT-PCR with primers speciﬁ  c for     -actin, MAP1B, eEF1a1, Iptr1/Pcp-1, 
Pcp-2, and Arc/Arg3.1 as indicated. The RT-PCRs in lane 1 was performed 
on 1/100 of the supernatant of lane 2. The asterisk in the bottom panel 
marks a band that runs at the height expected for the product of the Arc/
Arg3.1 pre-mRNA. The migration of DNA markers is indicated on the left 
of each panel.     
  Figure 4.       Characterization of the LSm1 mRNP by sucrose gradient cen-
trifugation.   (A) Rat brain extract was fractionated by sucrose gradient cen-
trifugation. The distribution of LSm1 protein was analyzed by SDS-PAGE 
and Western blotting (top) and the distribution of the major RNAs was ana-
lyzed by agarose gel electrophoresis and ethidium bromide staining (bot-
tom). The migration of a molecular mass marker is indicated on the left of 
the top panel. (B) Rat brain extract was UV irradiated, and then fractioned 
by sucrose gradient centrifugation. Even-numbered fractions were diluted 
with RIPA buffer and precipitated with     -LSm1 antibodies. Coprecipitating 
MAP1B mRNAs (top) and     -actin (bottom) were detected by RT-PCR. PCR 
products were separated on agarose gels and ethidium bromide stained. 
The migration of DNA markers is indicated on the left.     JCB • VOLUME 184 • NUMBER 3 • 2009  428
bottom (fractions 2  –  4), middle (fractions 5  –  7), and top (frac-
tions 8  –  10). The last two fractions were discarded, thus elimi-
nating the major part of LSm1 that is not incorporated into 
complexes of meaningful size and that would only cause back-
ground in the following analysis. After    -LSm1  immunopre-
cipitation, copurifying   -actin mRNA was revealed by RT-PCR. 
  Fig. 5   A shows that the     -actin mRNA is present in all three 
regions of the gradient (lanes 1, 4, and 7) and strongly copre-
cipitates with LSm1 (lanes 3, 6, and 9). Immunoprecipitation 
with mock IgGs yielded little (  Fig. 5   A, lane 2) or no back-
ground signal (  Fig. 5   A, lanes 5 and 8); the little background 
in lane 2 is caused by the fact that the signal in the bottom 
fraction was stronger than in the other two, resulting in satu-
rated bands for input and immunoprecipitation and detection 
of the slight background. 
  mRNAs are stabilized by the presence of the poly(A) tail. 
It was therefore interesting to detect the poly(A) tail and mea-
sure its length, which also gives some indication to the transla-
tional status. Available methods for poly(A) length measurement 
are all rather ineffi  cient and require substantial amounts of 
RNA, more than can be obtained in immunoprecipitations. We 
therefore devised a new method that uses a Klenow fi  ll-in reac-
tion to tag the poly(A) tail with a specifi  c sequence and that 
works with low amounts of RNA (the method is described in 
Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb
.200807033/DC1). Analysis of sucrose gradient/immuno-
precipitation double-purifi  ed actin mRNAs shows that, similar 
to the input mRNAs, the poly(A) length shows a bipartite dis-
tribution, with the majority of the signal in a peak that corre-
sponds to 50  –  100 nucleotides of poly(A). A second peak 
corresponds to   >  200 nucleotides. A similar picture is observed 
for the eEF1    1 mRNA (  Fig. 5 B  , bottom), and the mRNAs iso-
lated from the bottom and middle fractions also show very 
similar distributions (not depicted). To quantify the result, the 
signal intensity along the respective lanes was plotted against 
the position on the gel. The corresponding poly(A) tail lengths 
were estimated from the molecular mass markers present on 
the same gel and are indicated on the x axis. As can be seen on 
  Fig. 5 B   (right), the profi  le does not signifi  cantly change. All 
mRNAs have poly(A) tails that are long enough to exclude on-
going mRNA degradation. 
  CPEB1 is present on dendritic mRNPs, regulates transla-
tion, and also modulates poly(A) tail length ( Mendez and Richter, 
2001  ). LSm1-associated proteins were purifi  ed by sucrose 
gradient/immunoprecipitation as above and analyzed by Western 
blotting. CPEB1 was specifi  cally present in LSm1 complexes 
from all three regions of the sucrose gradient (  Fig. 5 C  , top), 
  Figure 5.       LSm1 mRNPs contain polyadenylated mRNAs, CPEB, and 
CBP80.   (A) Rat brain extracts were separated as before and three fractions 
were collected: bottom (equivalent to fractions 2  –  4 in   Fig. 4 A  ), middle 
(fractions 5  –  7 in   Fig. 4 A  ), and top (fractions 8  –  10 in   Fig. 4 A  ). mRNP 
complexes were immunoprecipitated with mock IgGs (lanes 2, 5, and 8) or 
with     -LSm1 antibodies (lanes 3, 6, and 9). Lanes 1, 4, and 7 show the RT-
PCR of 2.5% of the respective inputs. RNA was isolated and     -actin mRNA 
was detected by RT-PCR. PCR products were analyzed by agarose gel elec-
trophoresis and ethidium bromide staining; DNA markers are indicated on 
the left. (B)     -Actin and eEF1    1 mRNAs were ampliﬁ  ed from a pool of the 
three fractions (lanes 2 and 3) or from total RNA isolated from the crude 
brain extract (lane 1) by the tag-addition poly(A) test (Fig. S2, available at 
http://www.jcb.org/cgi/content/full/jcb.200807033/DC1). The lanes 
were scanned and the intensity is plotted on the right. The y axis gives 
the signal intensity relative to the peak of each lane. On the x axis, the 
position is plotted. Approximate poly(A) tail lengths were estimated from 
the molecular markers and the length of the amplicons without poly(A). The 
asterisk in the eEF1    1 panel indicates an artifact that is not dependent on 
tagging of the mRNA (Fig. S2). (C) Proteins were isolated from the three 
fractions immunopuriﬁ  ed as in A, and the following proteins were detected 
by Western blotting (from top to bottom): CPEB, eIF4E, Dcp1a, CBP80, 
rS6, rL11, and SMN. The position of the speciﬁ  c bands are indicated by 
arrows on the right and the migration of molecular mass markers on the 
left; asterisks designate bands that derive from the antibodies used in the 
immunoprecipitations and that are therefore present in high concentration 
on the blot. Lanes 1, 4, and 7 show the input (10% of the immunoprecipi-
tated material), lanes 2, 5, and 8 the mock precipitation with nonspeciﬁ  c 
IgGs, and lanes 3, 6, and 9 the speciﬁ  c     -LSm1 immunoprecipitations.     
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that the interaction is mostly restricted to the top fraction con-
taining the lightest complexes, as if SMN is part only of a subset 
of LSm1 complexes. 
  Dendritic LSm1 colocalizes with CBP80, 
but not Dcp1a 
  So far, we have biochemically characterized a stable LSm1 
complex that contains several mRNAs that are also found in the 
dendrites. To demonstrate that the complex actually is dendritic, 
we studied the subcellular localization of the involved proteins 
in primary neurons. We know that LSm1 resides in the dendritic 
compartment (  Figs. 1 and 2  ), and the same is true for CPEB and 
eIF4E (  Huang et al., 2003  ;   Smart et al., 2003  ). We therefore 
looked at the cap-binding protein in our complex. In primary 
neurons, CBP80 is detected in the cell bodies and in particular 
in the nucleus, as expected. Signifi  cantly, it is clearly also pres-
ent along the dendrites (  Fig. 6 A  ). We expressed fl  uorescent ver-
sions of the LSm proteins (tagged with YPet;   Nguyen and 
Daugherty, 2005  ) and coexpressed LSm1 and LSm4 because 
LSm subcomplexes give more specifi  c localization signals 
( Ingelfi  nger et al., 2002  ). We further used a neuron-specifi  c pro-
moter to better control expression levels and better reveal 
cellular structures. The resulting pattern faithfully reproduces 
the localization of the endogenous LSm1 and LSm4 proteins 
(compare   Fig. 6 B   with   Fig. 1  ). Signifi  cantly, several dendritic 
spots of LSm1/4 enrichment coincide with CBP80 foci (  Fig. 6 C  , 
yellow arrows). Further, we transfected with YPet-Dcp1a and 
counterstained with     -LSm1 antibodies. YPet-Dcp1a is ex-
pressed in granular structures in the cell body (  Fig. 6 E  ) that co-
localize with LSm1 and therefore appear as bright yellow spots 
in the merged image. These structures presumably correspond 
to the mRNA-degrading P bodies that were observed in undif-
ferentiated cell lines (  Ingelfi  nger et al., 2002  ;   Cougot et al., 
2004  ). Note that P bodies are not homogenous macromolecular 
complexes and colocalization of LSm1 and Dcp1a in the cell 
body therefore does not contradict our fi  nding that they do not 
indicating that LSm1 mRNPs indeed have the potential to be 
activated by cytoplasmic polyadenylation. 
  Further, functional mRNAs have an m 
7  G cap structure at 
their 5     terminus, which is bound by the translation initiation fac-
tor eIF4E. eIF4E is present mainly in the top fraction (  Fig. 5 C  , 
second panel, lane 7), and only minor amounts are found in the 
middle part of the gradient (  Fig. 5 C  , second panel, lane 4). In 
none of the fractions eIF4E precipitated with LSm1 (  Fig. 5 C  , 
lanes 3, 6, and 9). If eIF4E is not bound to the cap, the decap-
ping enzyme that competes with eIF4E may be present on the 
mRNP. The Dcp1a subunit of the enzyme is found in all three 
fractions of the gradient (  Fig. 5 C  , third panel, lanes 1, 4, and 7), 
but it does not coprecipitate with LSm1. Probably, the P bodies 
in the cell bodies that contain LSm1 and Dcp1a disintegrate 
during the purifi  cation scheme. That leaves only the nuclear 
cap-binding complex, which binds to the cap during maturation 
of the mRNA and its export from the nucleus. We verifi  ed the 
presence of the bigger subunit CBP80: it was detected in all 
three zones of the gradient and it coprecipitated with LSm1 in 
signifi  cant amounts in all three fractions ( Fig. 5 C , fourth panel). 
We conclude that the LSm1 mRNPs have CBP80 bound to the 
5     cap structure. 
  To further characterize the LSm1-associated mRNPs, we 
investigated association with translational markers. FMRP, an 
important neuronal and dendritic translational regulator (  Napoli 
et al., 2008  ), does not coprecipitate with LSm1 and colocalizes 
only to a very small extent with dendritic LSm1 (unpublished 
data). The ribosomal protein S6 coprecipitated in all three re-
gions of the gradient, indicating association with the small ribo-
somal subunit ( Fig. 5 C , fi  fth panel). The large ribosomal subunit 
protein L11, instead, is not signifi  cantly associated with LSm1 
mRNPs (  Fig. 5 C  , sixth panel), suggesting the presence of 
stalled 48S initiation complexes. Finally, the LSm complex in-
teracts, at least in vitro, with SMN (  Friesen and Dreyfuss, 2000  ; 
  Brahms et al., 2001  ). The interaction is confi  rmed in the brain 
extract (  Fig. 5 C  , seventh panel). It should be noted, however, 
  Figure 6.       Dendritic LSm1 colocalizes with 
CBP80, but not with hDcp1a.   Hippocampal 
neurons (10 DIV) were transfected simultane-
ously with YPet-LSm1 and YPet-LSm4 and coun-
terstained with     -CBP80 antibodies (A  –  C) 
or transfected with YPet-hDcp1a and counter-
stained with     -LSm1 (D  –  G). The cells were 
further stained with     -MAP2 to conﬁ  rm  their 
neuronal identity (not depicted). Shown are 
confocal optical slices. The YFP channel is 
shown in green and the antibodies in red. The 
right column shows the merged picture. The 
details highlighted in A  –  C are shown below 
the respective panels; the detail in F is shown 
in G. Bars, 10   μ  m.     JCB • VOLUME 184 • NUMBER 3 • 2009  430
distance from both synaptophysin-positive foci and sites of 
F-actin enrichment, i.e., that are in close vicinity to a functional 
synapse. The mask is shown in green in the fourth row (  Fig. 8, 
A and B  ). As is evident from the picture, some LSm1 signal 
(  Fig. 8, A and B  , fourth row, red) is found in the vicinity of un-
treated synapses (left) and therefore appears yellow in the 
merged picture (arrows). After DHPG treatment, the signal 
within the mask increased (  Fig. 8, A and B  , right). Statistical 
evaluation of at least 30 neurons for each condition confi  rmed 
the data: the LSm1 signal in vicinity of the synapses increased 
by 44% (P   <   0.001;   Fig. 8 C  ) and CBP80 by 30% (P   <   0.01). We 
therefore conclude that both LSm1 and CBP80 move into the 
spines upon stimulation, which is highly indicative that transla-
tion of LSM1/CBP80 mRNPs is activated. 
  Discussion 
  In this paper, we describe the composition of an mRNP that is 
localized in the dendrites of various types of neurons in vitro 
and in vivo. Three characteristics of this mRNP are remarkable. 
First, it contains the LSm proteins LSm1 and LSm4, and pre-
sumably fi  ve other LSm proteins as well, to complete the hep-
tamer (see Introduction). LSm proteins are auxiliary factors of 
mRNA decapping in yeast and components of the P bodies in 
interact (  Fig. 5 C  ). Outside the cell body, the two proteins seg-
regate: Dcp1a granules contain little or no LSm1 and thus ap-
pear green in the merged image (  Fig. 6 G  ). We conclude that 
LSm1 granules in the dendrite contain CBP80, but no Dcp1a. In 
the cell body, they mostly contain Dcp1a. The biochemically 
characterized LSm1 particles (  Fig. 5  ) therefore most likely rep-
resent the dendritic fraction. 
  LSm1-CBP80 accompanies the mRNAs 
from the nucleus to the spines 
  The presence of the nuclear cap-binding protein in the LSm1 
mRNP may suggest that the complex is assembled in the nu-
cleus before exit to the cytoplasm. LSm1 has so far been described 
as entirely cytoplasmic. Careful inspection of LSm1-stained pri-
mary neurons, however, revealed some nuclear staining with 
certain variability between cells (  Fig. 7   and not depicted), indi-
cating that LSm1 is not rigorously excluded from the nucleus. 
The predominantly cytoplasmic localization in the steady state 
could then be driven by the effi  cient transport of newly synthe-
sized mRNAs into the cytoplasm. To test this hypothesis, we in-
hibited de novo synthesis of mRNAs, and hence mRNA export 
to the cytoplasm, by actinomycin D (ActD) treatment of pri-
mary hippocampal neurons for 3 h.   Fig. 7   shows the projection 
of confocal slices that span the entire cell. A typical cell in the 
untreated sample (  Fig. 7 A  , top) shows only a faint LSm1 signal 
(red) that colocalizes with the nucleus (Hoechst staining shown 
as green); the projection even exaggerates the true amount of 
nuclear LSm1, as it includes a thin layer of cytoplasm under-
neath and above the nucleus (not depicted). ActD treatment, in-
stead, signifi  cantly increases the amount of LSm1 in the nucleus 
(  Fig. 7 A  , bottom). Because of the variability between cells (see 
beginning of paragraph), we wanted to confi  rm the data by per-
forming a statistical analysis. LSm1 signal that colocalized with 
the nucleus was quantifi  ed and normalized fi  rst to the area of the 
nuclear projection and then to the mean LSm1 nuclear staining 
in the control samples. As shown in   Fig. 7   B, ActD induces a 
twofold increase in the mean nuclear LSm1 signal (  n   = 6; P   <   
0.05 in Student  ’  s   t   test). We conclude that LSm1 clearly has a 
nuclear phase. Although we cannot exclude collateral effects of 
the ActD treatment, the signifi  cant increase in nuclear LSm1 is 
in agreement with the hypothesis that LSm1 exits the nucleus 
together with newly formed mRNPs. 
  Translation of some dendritic mRNAs is activated upon 
synaptic stimulation, and a hallmark of this activation is the con-
comitant migration of mRNP components into the stimulated 
spines (see Introduction). We therefore tested whether synaptic 
stimulation leads to a redistribution of LSm1. Indeed, a 5-min 
treatment with (S)-3,5-dihydroxyphenylglycine (DHPG) causes 
a signifi  cant increase of both the LSm1 and CBP80 signal in the 
dendrites of primary hippocampal neurons. To verify that the 
dendrites carry functional synapses, we performed a triple stain-
ing with an     -synaptophysin antibody that marks presynaptic 
sites ( Fig. 8, A and B, top rows ), phalloidin that highlights points 
of F-actin enrichment and hence dendrites (second rows), and 
    -LSm1 or     -CBP80 antibodies (third rows). A mask was cre-
ated using a dedicated algorithm (see Materials and methods), 
which marks all the points in the image that are within a 0.4-  μ  m 
  Figure 7.       ActD treatment enhances LSm1 staining in the nucleus.   (A) Con-
trol hippocampal neurons (18 DIV; a  –  c) or hippocampal neurons treated 
for 3 h with ActD (18 DIV; d  –  f) were stained with     -LSm1 antibodies 
(a and d) and Hoechst (b and e). A stack of 8  –  12 optical slices was 
recorded at the confocal microscope. Shown is the projection of all slices 
using the Z project algorithm. Panels c and f show the overlay of the LSm1 
and the Hoechst staining. Bars, 10   μ  m. (B) LSm1 colocalization with the 
nucleus of six neurons was quantiﬁ  ed and normalized for the area of the 
nucleus. Shown is the mean intensity in the control nuclei (arbitrarily set to 1) 
and in the ActD-treated nuclei. Error bars indicate the standard error. 
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enzyme only in the cell body. In the dendrites, the two proteins 
segregate (  Fig. 6  ), indicating that mRNA degradation and 
LSm1-associated mRNP localization are separated in space. 
This notion is further supported by the absence of Dcp1a in pu-
rifi  ed LSm1 particles (  Fig. 5  ). Therefore the neuronal mRNP 
granules are heterogeneous, at least in mammalian neurons, in 
that dendritic LSm1-mRNPs and P bodies are distinct. 
  In the central nervous system, we observed LSm1 in neu-
ronal dendrites ( Figs. 1 and 2 ), but expression levels vary widely, 
with dendrites of pyramidal neurons and especially of Purkinje 
cells labeled most. The selectivity is even more pronounced 
when looking at axonal processes: in the brain, we could not 
detect LSm1 in axonal fi  bers or presynaptic structures. In the 
spinal cord, instead, fi  bers that can be anatomically defi  ned as 
axonal projections, most likely of the     -motor neurons, are 
clearly LSm1 positive (  Fig. 2  ). LSm1 thus appears to have a 
function that is either specifi  c for certain neuron subtypes or 
all eukaryotes (see Introduction). In neuronal dendrites, instead, 
LSm1 associates with stable mRNPs that can be isolated and 
characterized. The presence of an intact poly(A) tail (  Fig. 5  ) and 
a m 
7  G cap (as indicated by the presence of a cap-binding factor; 
  Fig. 5  ) further support the notion that the respective mRNAs are 
not undergoing degradation. The presence of LSm1 in these 
neuronal mRNPs further underlines the overlap between the 
various types of RNA granules, P bodies and stress granules in 
cell lines, maternally stored mRNPs in   Drosophila melanogas-
ter   oocytes, and neuronal transport mRNPs (  Anderson and 
Kedersha, 2006  ). The oskar mRNP in   Drosophila   oocytes  ( Lin 
et al., 2006  ) and neuronal Staufen-containing transport mRNPs 
(  Barbee et al., 2006  ) contain the decapping enzyme Dcp1/
Dcp1a even when their function does not involve mRNA degra-
dation, indicating that the different functions of the P body  –  type 
granules are not physically separated. The mammalian neuronal 
LSm1 protein, instead, coincides with the Dcp1a-decapping 
  Figure 8.       DHPG stimulation causes a relocaliza-
tion of LSm1 toward the synapses.   (A) Hippocam-
pal cells were ﬁ  xed directly (left) or after a 5-min 
stimulation with DHPG in the medium (right). Cells 
were stained with     -synaptophysin (top), with 
phalloidin (second row), as well as with poly-
clonal     -LSm1 (third row). Shown are single opti-
cal slices taken on the confocal microscope: the 
top three rows show the single channels and the 
bottom row shows a picture that merges the red 
channel of LSm1 with a mask that highlights the 
synapses and the surrounding area to a distance 
of     0.4   μ  m (green). Synapses appear mostly 
green in the control, but much more yellow after 
stimulation (arrows). (B) As in A, but stained with 
    -CBP80 antibodies instead of     -LSm1. Bars, 10   μ  m. 
(C) LSm1 and CBP80 immunoﬂ   uorescence in-
tensity, respectively, that fell inside the synapses 
mask was integrated for at least 30 neurons of 
16  –  18 DIV and was normalized ﬁ  rst for the area 
and then for the average control without DHPG 
stimulation. The resulting values and the signiﬁ  -
cance according to Student  ’  s   t   test are shown 
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early commitment to transport. A nuclear commitment to cyto-
plasmic transport has been shown before for the   oskar   mRNAs 
in   Drosophila   oocytes (  Hachet and Ephrussi, 2004  ) and may 
also play a role in   Xenopus laevis   oocytes (  Kress et al., 2004  ). 
The ZBP1 transport mRNP in HEK cells also contains CBP80 
(  J  ø  nson et al., 2007  ), suggesting that the nuclear history of 
mRNA transport is a wide-spread phenomenon. LSm1 is re-
garded as a cytoplasmic protein. Contrary to this belief, pri-
mary neurons have a variable fraction of the protein in the 
nucleus, and inhibition of ex novo formation of mRNPs by 
transcription repression signifi   cantly increases the nuclear 
LSm1 fraction (  Fig. 7  ). This gives a fi  rst indication that LSm1 
can shuttle between the nucleus and the cytoplasm, with the 
nuclear export depending on mRNP export, and the LSm1/
CBP80 mRNP could well assemble in the nucleus. 
  Finally, the LSm1 mRNPs associate with CPEB (  Fig. 5  ). 
CPEB binds to the cytoplasmic polyadenylation element that is 
present on some mRNAs and can trigger, upon glutamergic 
stimulation, elongation of the poly(A) tails and hence transla-
tion activation of the respective mRNPs (  Wu et al., 1998  ;   Wells 
et al., 2001  ). CPEB is present at the dendrites and enters into the 
spines upon synaptic stimulation (  Huang et al., 2003  ), similar to 
what we observe for LSm1 and CBP80. Our poly(A) tail length 
measurement shows that LSm1-associated mRNAs are not 
deadenylated; only a subpopulation of the     -actin mRNA might 
be. There are two possible interpretations: CPEB might have a 
role in dendritic mRNA transport beyond poly(A) length con-
trol (e.g., CPEB is present on mRNPs during transport [  Huang 
et al., 2003  ]) and/or only a subset of the LSm1-associated 
mRNAs, whose identity we do not currently know, contain criti-
cally short poly(A) tails so that their translational activation re-
quires cytoplasmic polyadenylation. 
  The model that emerges from our data is depicted in   Fig. 9  . 
LSm1 and CBP80 assemble in the nucleus onto mRNPs that are 
destined to be transported into the dendrites. Likely, the pioneer 
round of translation is initiated, but then blocked at the 48S pre-
translation complex. It remains to be seen at what stage CPEB 
joins the complex; the fact that it is present during transport along 
the dendrites (  Huang et al., 2003  ) implies that it also enters at an 
early time point. All the key players in this mRNP have been 
shown previously or in this manuscript to be present at the den-
drites, and it is therefore straightforward to assume that they are 
part of the migrating mRNP. Finally, at least LSm1 and CBP80 
shift into the dendritic spines when the synapses are stimulated, 
which is causing translational activation. We cannot exclude the 
possibility that translation then takes place in the presence of both 
factors, e.g., by internal ribosomal entry site  –  mediated transla-
tion initiation (  Pinkstaff et al., 2001  ), but we think it is more 
likely they are replaced in loco to give way for normal, eIF4E-
dependent translation (  Smart et al., 2003  ). This model sheds new 
light on the dendritic targeting and transport of mRNPs and will 
thus be an important stimulus for future studies. 
  Materials and methods 
  All animal experiments in this study were performed using Wistar rats 
and C56/BL6 mice (Harlan or Charles River Laboratories) that were 
that requires more LSm1 in certain neurons than in others. This 
is remarkable with respect to the interaction of the LSm proteins 
with the SMN protein in vitro (  Brahms et al., 2001  ;   Friesen 
et al., 2001  ) and in brain extracts (  Fig. 5  ): because of the selec-
tive effect of SMN depletion on     -motor neurons, it has been 
hypothesized that the protein may have a neuron-specifi  c role in 
addition to its housekeeping function (  Sendtner, 2001  ). Further, 
the primary defect in the motor neurons is a failure to mature 
and/or maintain the axonal projection. The LSm complex might 
therefore be the missing link between SMN insuffi  ciency and 
motor neuron degeneration. 
  LSm1 has been primarily described as an auxiliary mRNA 
degradation factor. Detailed analysis in yeast shows that Lsm1p 
regulates translation ( Holmes et al., 2004 ) and the LSm1-associated 
factor Pat1p inhibits translation initiation (  Coller and Parker, 
2005  ). Similarly, mammalian LSm acts upstream of the degrad-
ing enzymes hDcp1a and hXrn1 (  Cougot et al., 2004  ;   Andrei 
et al., 2005  ). We therefore believe that the neuronal LSm1 mRNPs 
will also be translationally silent. An indication of this is the 
size distribution of LSm1 on sucrose gradients does not follow 
a  typical   “ polysome ”   profi  le, with a second peak of more than 
80S. More importantly, the mRNP contains the nuclear cap-
binding protein, strongly indicating that the mRNA has not yet 
undergone its pioneer round of translation (see next paragraph). 
LSm1 mRNPs associate with the small ribosomal subunit, 
whereas no signifi  cant amounts of the large subunit were ob-
served (  Fig. 5  ), which might hint at the possibility that the 
LSm1 mRNPs represent stalled 48S preinitiation complexes. 
They may in this respect resemble transport mRNPs that form 
around the zip-code binding protein ZBP1, in which parts of the 
small, but not of the large ribosomal subunit have been detected 
(  J  ø  nson et al., 2007  ). Consistently, ZBP1 inhibits translation at 
the 48S stage (  H  ü  ttelmaier et al., 2005  ). 
  Remarkably, the LSm1 mRNPs contain the   “  nuclear  ”   cap-
binding protein CBP80 instead of the translation initiation fac-
tor eIF4E. This protein binds to mRNA precursors in the nucleus 
(  Izaurralde et al., 1994  ) and remains bound to the mRNA 
throughout its maturation and export from the nucleus (  Visa 
et al., 1996  ). In the cytoplasm, CBP80 is removed in a pioneer 
round of translation and eIF4E takes its place (  Ishigaki et al., 
2001  ;   Lejeune et al., 2002  ). CBP80 so far has not been impli-
cated in neuronal mRNA transport. Here we show that CBP80 
is present along the dendrites (  Figs. 6  ). mGluR-mediated trans-
lational stimulation causes a signifi  cant shift of CBP80 toward 
the synapses, which is a hallmark of the activation of local pro-
tein synthesis (  Fig. 8  ). These fi  ndings together strongly suggest 
that CBP80 has a role during dendritic mRNP transport. 
  First of all, this implies that the respective mRNAs have 
not yet undergone the pioneer round of translation when they 
are transported into the dendrites. Quite possibly, they were 
committed for dendritic transport already in the nucleus (see 
also below). While this study was under way, it was reported 
that components of the exon junction complex are also found 
in the dendrites (  Giorgi et al., 2007  ). The exon junction com-
plex is deposited onto the mRNA in the nucleus and is likewise 
stripped off the mRNA by the pioneer round of translation, and 
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actinomycin D for 3 h (ActD; Sigma-Aldrich) or with 100   μ  M DHPG for 
5 min (Sigma-Aldrich). Cells were transfected with calcium phosphate pre-
cipitations at 10 DIV. In brief, 4   μ  g DNA were mixed with calcium chloride 
and precipitated with HBSS phosphate buffer (PB). The microprecipitates 
were applied to the cells for 45 min, and then washed off. Cells were ﬁ  xed 
and stained after 20 h of expression. 
  For immunoﬂ   uorescence analysis, cells were ﬁ   xed with 2% PFA, 
permeabilized with 0.2% Triton X-100, and blocked with 10% FBS in PBS. 
Fixed cells were incubated for 1 h at room temperature with the primary 
antibodies diluted in 10% FBS in PBS. The cells were washed three times 
with PBS and incubated for 1 h at room temperature with Cy2-conjugated 
    -mouse IgG and Cy3-conjugated     -rabbit IgG secondary antibodies (GE 
Healthcare) and washed again three times with PBS. Where applicable, 
cells were stained with 50   μ  g/ml phalloidin-FITC conjugate (Sigma-
Aldrich) in PBS for 25 min at RT and washed three times. Transfections 
were counterstained using Paciﬁ  c blue  –  conjugated secondary antibodies. 
Coverslips were embedded in Mowiol (EMD) or Gelmount (Biomeda). Im-
ages were recorded using the confocal scanning microscope (LSM 510 
[Carl Zeiss, Inc.], 63/1.4 objective, or Radiance 2100 [Bio-Rad Labora-
tories], 60/1.4 objective) and analyzed using the Carl Zeiss, Inc. soft-
ware as well as the ImageJ program (version 1.40). The mask to identify 
active synapses and surrounding areas was generated on the basis of 
spatial correlation of the synaptophysin and the phalloidin staining, large 
accumulations were discarded from analysis to prevent misinterpretations. 
In brief, an algorithm was realized with the ImageJ package and the 
JACoP plug-in (  Bolte and Cordeli  è  res, 2006  ; http://rsb.info.nih.gov/ij/) 
that takes the overlap of presynaptic and postsynaptic signal and enlarges 
it three times by one pixel. In this way, areas within     400 nm or less were 
identiﬁ  ed as synapses. 
  Tissue preparation and immunoﬂ  uorescence staining 
  Three adult male rats weighing 200  –  250 g were transcardially perfused 
under deep anesthesia (60 mg/kg Nembutal i.p.) with 150 ml of 0.9% sa-
line at room temperature followed by 200 ml of cold 4% PFA in 0.1 M PB, 
pH 7.4. Brains were dissected, postﬁ  xed for 2 h at room temperature, and 
cryoprotected in 30% sucrose/PB at 4  °  C. They were then frozen with dry 
ice and cut into 40-  μ  m transverse sections with a freezing microtome. All 
antibody solutions were prepared in PB and 0.3% Triton X-100 and incu-
bated overnight at room temperature. After incubation with the cocktail of 
primary antibodies, the sections were washed three times in PB and subse-
quently incubated for 2 h at room temperature in a cocktail of Cy2-conju-
gated donkey     -mouse IgG and Cy3-conjugated donkey     -rabbit IgG 
secondary antibodies (1:100 each; Jackson ImmunoResearch Laborato-
ries). Sections were washed three times in PB, mounted on gelatin-coated 
slides, and coverslipped in Gelmount (Biomeda). Anatomical boundaries 
and nomenclature were named according to   Paxinos and Watson   (  1994  ). 
Images were acquired on a confocal microscope (10/0.3, 20/0.5, and 
63/1.4 objectives) and exported in JPEG format; the contrast and bright-
ness were adjusted and ﬁ  nal plates were composed with Adobe Illustrator 
9 or Corel Draw 9. 
  Rat brain extracts and immunoprecipitation 
  Whole brain (postnatal day 1 or 2 rats) was homogenized by dounce ho-
mogenization in 3 ml/brain of ice-cold IMAC buffer (  Kanai et al., 2004  ) 
in the presence of 0.1 mM PMSF. The lysate was centrifuged at 15,000   g   
for 5 min at 4  °  C. Supernatants were pooled and total protein concentra-
tion was estimated by the Bradford assay (Bio-Rad Laboratories). For 
immunoprecipitations, brain lysate (750   μ  g of total protein) in 300   μ  l IP 
buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, and 0.1% Triton X-100) 
were precipitated with 20   μ  l of afﬁ  nity-puriﬁ  ed     -LSm1 antibodies immobi-
lized on protein A  –  Sepharose (GE Healthcare). After washing with IP buf-
fer, bound proteins were eluted with SDS loading buffer, resolved by 
SDS-PAGE, and analyzed by Western blotting, using the enhanced chemi-
luminescence detection system (GE Healthcare). 
  For cross-linking experiments, a postnatal day 2 rat brain was 
minced, divided into equal parts, and irradiated with a germicidal lamp 
for 0, 45, and 90 s. After irradiation, the tissue was homogenized in 1 ml 
RIPA buffer (150 mM NaCl, 50 mM Tris-Cl, pH 7.5, 1% NP-40, and 1% 
DOC), and the extract was cleared by centrifugation. Immunoprecipitation 
was performed as described above using RIPA buffer for the washes. 
  To reduce the RNA background in immunoprecipitation/RT-PCR ex-
periments, the brain lysate was precleared in such experiments for 1 h 
with 20   μ  l protein A  –  Sepharose (preblocked with 0.3% BSA in PBS and 
100   μ  g/ml of   Escherichia coli   tRNA); otherwise, the immunoprecipitation 
was performed as above using IP buffer in the wash steps. Bound RNAs 
group-housed in standard cages and kept under a 12-h light/dark cycle 
with food and water ad libitum. All animal experiments were performed 
in accordance to the Italian law on the use and care of laboratory ani-
mals (DL 116\92). 
  The antibodies used in this study were as follows: afﬁ  nity-puriﬁ  ed 
rabbit     -LSm1 and     -LSm4 (  Ingelﬁ  nger et al., 2002  ); mouse SMI31 and 
SMI32 (Sternberger); mouse     -Calbindin (Swant); mouse     -glial ﬁ  brillary 
acidic protein (Sigma-Aldrich); mouse     -synaptophysin (Millipore); rabbit     -
CPEB1 (gift from D. Wells, Yale University, New Haven, CT); mouse     -MAP2 
(Sigma-Aldrich);     -SMN (Signal Transduction); mouse     -eIF4E (Santa Cruz 
Biotechnology, Inc.); goat     -orexin (Santa Cruz Biotechnology, Inc.); rabbit 
    -Dcp1a (gift from J. Lykke-Andersen, University of Colorado, Boulder, CO); 
rabbit     -rS6 and     -L11 (gift from F. Lorreni, University of Rome, Rome, Italy); 
and rabbit     -CBP80 (gift from I. Mattaj, European Molecular Biology Labo-
ratory, Heidelberg, Germany). 
  For neuronal transfections, the CMV promoter of pcDNA3 was re-
placed with a cassette of the rat tubulin     1 promoter (position     989 to 
+93;   Gloster et al., 1994  ) and the yellow ﬂ  uorescent YPet protein (  Nguyen 
and Daugherty, 2005  ). Downstream of YPet, the ORFs encoding LSm1, 
LSm4 (  Ingelﬁ  nger et al., 2002  ), and Dcp1a (ampliﬁ  ed from cDNA using 
primers based on   Lykke-Andersen, 2002  ) were inserted; the integrity of the 
ORFs was veriﬁ  ed by sequencing. 
  Primary neuron culture and immunoﬂ  uorescence analysis 
  Spinal cords were obtained from embryonic day 12  –  14 fetal rats. After re-
moval of the dorsal root ganglia, 10  –  14 spinal cords were dissected, 
washed with 5 ml of Earl  ’  s Balanced Salt Solution, and centrifuged for 2 min 
at 150   g  . The tissue was resuspended and incubated for 15 min at 37  °  C 
with 0.02% trypsin followed by addition of DNase I (80   μ  g/ml ﬁ  nal) and 
trypsin inhibitor (0.52 mg/ml). Digested tissues were mechanically dissoci-
ated and centrifuged at 150   g   for 10 min. The dissociated cells were 
plated at a density of 12   ×   10 
4   cells/cm 
2   in MEM (Invitrogen) supple-
mented with 10% heat-inactivated FBS or in Neurobasal media (Invitrogen) 
supplemented with B27. Rat Purkinje cells were obtained from postnatal 
day 7 rat cerebellum as described previously (  Gallo et al., 1982  ). 
  Hippocampal neuron cultures were prepared from an embryonic 
day 19 mouse. The brains were removed and hippocampi were freed of 
meninges, treated with 0.025% trypsin, minced, and plated on poly-  L  -
lysine (Sigma-Aldrich) wells in Neurobasal supplemented with 2% B27. 
Neurons were maintained at 37  °  C and 5% CO  2  . For drug treatment, cells 
were treated at 16  –  18 d in vitro (DIV) before ﬁ  xation with 10   μ  g/ml 
  Figure 9.       Model.   mRNPs bound for dendritic transport associate with 
the LSm complex already in the nucleus, with the nuclear cap-binding 
protein still attached. Whether CPEB joins the complex also in the nucleus, 
or only after export, remains to be elucidated. The mRNP carrying these 
markers is then found in the dendrite and is shifted as such into stimulated 
dendritic spines. There, the mRNA is presumably liberated to allow eIF4E-
dependent translation.     JCB • VOLUME 184 • NUMBER 3 • 2009  434
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were eluted in elution buffer (0.2 M NaOAc, pH 5.2, 0.2% SDS, and 1 
mM EDTA), puriﬁ  ed by phenol-chloroform extraction, and concentrated by 
ethanol precipitation. cDNAs were synthesized using p(dN  6  ) and M-MuLV 
reverse transcription (New England BioLabs, Inc.) in 20   μ  l of reaction 
volume as described by the manufacturer. 2   μ  l of the reaction mixture 
was used in standard PCR reactions using Taq polymerase (New England 
Biolabs, Inc.). Primers are listed in Table S1 (available at http://www.jcb
.org/cgi/content/full/jcb.200807033/DC1). 
  In the coupled sucrose gradient/immunoprecipitation experiments, 
brain lysate equivalent to 2.5 mg of total protein was loaded onto each 
SW41 tube with a 10  –  45% sucrose gradient, prepared in 10 mM Hepes-
KOH, pH 7.5, and 150 mM KOAc, and centrifuged at 40,000 rpm for 
2 h and 10 min. After harvesting the gradient, the respective fractions of 
four to six gradient tubes were pooled and Triton X-100 was added to 
0.1%. It was then incubated for 1 h at 4  °  C with the respective antibodies 
immobilized to 150   μ  l of protein A  –  Sepharose. The beads were washed 
three times with 10 mM Hepes-KOH, pH 7.5, 150 mM KOAc, and 0.1% 
Triton X-100, and bound complexes were eluted with elution buffer. RNAs 
and proteins were recovered by EtOH and acetone precipitation, respec-
tively, and analyzed as before. The tag-addition poly(A) test method is de-
scribed in detail in Fig. S2. 
  Online supplemental material 
  Fig. S1 shows the speciﬁ  city of the anti-LSm1 antibodies. Fig. S2 shows 
further regions of the central nervous system stained for LSm1. Fig. S3 
explains and shows the validation of the poly(A) test method. Table S1 
lists all the primers used in the study and the exon they anneal to. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200807033/DC1. 
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